PEBP1 and malignant colon neoplasm: Using colon cancer cell lines as models, they reported a link between RKIP-KEAP 1-NRF2 to explain the drug resistance induced by RKIP and suggest this pathway as a possible target for personalized therapeutic intervention in RKIP depleted cancers [59].